Viewing StudyNCT00004935



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004935
Status: TERMINATED
Last Update Posted: 2023-04-18
First Post: 2000-03-07

Brief Title: Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
Sponsor: Swiss Group for Clinical Cancer Research
Organization: Swiss Group for Clinical Cancer Research

Key Dates - Follows AllAPIJSON File Order

Start Date: 1999-08-30
Start Date Type: ACTUAL
Primary Completion Date: 2014-11-06
Primary Completion Date Type: ACTUAL
Completion Date: 2022-03-31
Completion Date Type: ACTUAL
First Submit Date: 2000-03-07
First Submit QC Date: January 26 2003
Study First Post Date: 2003-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-04-12
Last Update Post Date: 2023-04-18
Last Update Post Date Type: ACTUAL